Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01138046
Brief Title: Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC

First Submitted : March 18, 2010
First Submitted that Met QC Criteria : June 3, 2010
First Posted : June 7, 2010 (Estimate)

Results First Submitted : September 15, 2014
Results First Submitted that Met QC Criteria : September 15, 2014
Results First Posted : September 19, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 29, 2014
Last Update Posted : October 7, 2014 (Estimate)